✦ LIBER ✦

Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature

✍ Scribed by Kluge, Michael; Schacht, Alexander; Himmerich, Hubertus; Rummel-Kluge, Christine; Wehmeier, Peter M.; Dalal, Mira; Hinze-Selch, Dunja; Kraus, Thomas; Dittmann, Ralf W.; Pollmächer, Thomas; Schuld, Andreas

Book ID: 122166859
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 236 KB
Volume: 152
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2013.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of bifeprunox in pat

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

LJP 394 for the prevention of renal flar

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study

✍ Donato Alarcón-Segovia; James A. Tumlin; Richard A. Furie; James D. McKay; Mario 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of

The image of patients and caregivers in

The image of patients and caregivers in the social perception of Alzheimer's disease - results from a literature review and a qualitative study considered with this target

✍ Stéphanie Pin Le Corre; Claire Scodellaro; Pierre Arwidson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

A 2-year phase 3 study of safety and eff

A 2-year phase 3 study of safety and efficacy of etanercept 50 mg twice weekly in patients with psoriasis: Results from the 3-month double-blind period

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Change in clinical status and side effec

Change in clinical status and side effects of patients treated with either olanzapine or risperidone: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study

✍ P.R. Gargoloff; R.A. O'Halloran; J.M. Boland; E. Brunner; M. Dossenbach; L. Levi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Impact of ustekinumab on health-related

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB